DEGARELIX
Showing 26 - 50 of 142
Prostate Cancer Trial in Los Angeles (degarelix, enzalutamide, trametinib)
Active, not recruiting
- Prostate Cancer
- degarelix
- +3 more
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Aug 25, 2022
Prostate Cancer, Stage IV Prostate Cancer Trial in Tampa (Luteinizing Hormone Releasing Hormone, New Hormonal Agent, Docetaxel)
Recruiting
- Prostate Cancer
- Stage IV Prostate Cancer
- Luteinizing Hormone Releasing Hormone
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Jun 1, 2022
Prostate Cancer Metastatic Trial in New York (REGN2810, Degarelix, Leuprolide Acetate)
Recruiting
- Prostate Cancer Metastatic
- REGN2810
- +3 more
-
New York, New YorkColumbia University Irving Medical Center
Mar 22, 2022
Prostate Cancer Trial in India (Degarelix)
Completed
- Prostate Cancer
- Degarelix
-
Bikaner, Rajasthan, India
- +18 more
Dec 14, 2021
Cognitive Impairment, Estrogen Deficiency, Menopause Trial in Aurora, Boulder (GnRHant + E2, GnRHant + Placebo)
Completed
- Cognitive Impairment
- +4 more
- GnRHant + E2
- GnRHant + Placebo
-
Aurora, Colorado
- +1 more
Jun 3, 2021
Prostate Cancer, Neoadjuvant Therapy, Androgen Antagonists Trial in Leuven (ARN-509, Degarelix, Placebo)
Recruiting
- Prostate Cancer
- +3 more
- ARN-509
- +2 more
-
Leuven, Vlaams-brabant, BelgiumUniversity Hospitals Leuven
Dec 23, 2020
Prostate Cancer Trial in Shanghai (drug, procedure, radiation)
Recruiting
- Prostate Cancer
- Leuprolide acetate
- +9 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 15, 2022
Stage IV Prostate Cancer Trial in Baltimore (procedure, drug, other, biological)
Completed
- Stage IV Prostate Cancer
- Cryosurgery
- +3 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Nov 11, 2021
Effect of ADT in Prostate Cancer Asia (READT Asia Study)
Recruiting
- Prostate Cancer
- Androgen deprivation therapy - bilateral orchidectomy
- +2 more
-
Shatin, Hong KongPrince of Wales Hospital
Dec 14, 2021
Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Stanford (radiation, drug, other)
Active, not recruiting
- Prostate Adenocarcinoma
- +4 more
- Internal Radiation Therapy
- +7 more
-
Stanford, CaliforniaStanford University, School of Medicine
Feb 1, 2022
Pregnancy, Ovarian Trial in ThessalonĂki (Degarelix)
Recruiting
- Pregnancy, Ovarian
- Degarelix
-
ThessalonĂki, GreeceAssisting Nature
Oct 6, 2020
Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte
Recruiting
- Castration-Sensitive Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Oct 7, 2022
Prostate Cancer Trial in United States (Degarelix, stereotactic body radiosurgery (SBRT))
Active, not recruiting
- Prostate Cancer
- Degarelix
- stereotactic body radiosurgery (SBRT)
-
Miami, Florida
- +9 more
Mar 1, 2022
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)
Active, not recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Abiraterone Acetate
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Replication of PRONOUNCE Prostate Cancer Trial in Healthcare
Active, not recruiting
- Prostate Cancer
- Degarelix
- Leuprolide
-
Boston, MassachusettsBrigham and Women's Hospital
May 18, 2021
Prostatic Tumors Trial in Korea, Republic of (Leuprorelin, Goserelin, Triptorelin)
Recruiting
- Prostatic Neoplasms
- Leuprorelin
- +6 more
-
Cheongju, Korea, Republic of
- +9 more
Jul 28, 2021
Prostate Cancer Trial in Turku (GnRH antagonist)
Recruiting
- Prostate Cancer
- GnRH antagonist
-
Turku, FinlandTurku University Hospital
Apr 8, 2021
Prostate Adenocarcinoma Trial in Duarte (drug, radiation, other)
Recruiting
- Prostate Adenocarcinoma
- Leuprolide Acetate
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 14, 2022
Prostatic Tumors Trial in London, Ottawa, Toronto (Degarelix)
Terminated
- Prostatic Neoplasms
- Degarelix
-
London, Ontario, Canada
- +2 more
May 5, 2020
Prostate Cancer Trial in Abbottsford, Surrey, Vancouver (Degarelix)
Completed
- Prostate Cancer
- Degarelix
-
Abbottsford, British Columbia, Canada
- +2 more
Jan 23, 2020
Prostate Cancer, Oligometastasis, Oligorecurrence Trial in United States (procedure, radiation, other, drug)
Recruiting
- Prostate Cancer
- +4 more
- PET-directed Local Therapy using Surgery
- +10 more
-
Long Beach, California
- +15 more
Jul 29, 2022
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Oligometastatic Prostate Carcinoma Trial in Houston
Withdrawn
- Biochemically Recurrent Prostate Carcinoma
- +5 more
- Apalutamide
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jan 14, 2021
Adenocarcinoma of Prostate Trial in France (Degarelix, Pelvic Radiotherapy)
Active, not recruiting
- Adenocarcinoma of Prostate
- Degarelix
- Pelvic Radiotherapy
-
Angers, France
- +38 more
May 11, 2022
Hormone Sensitive Prostate Cancer, Prostate Cancer, Cardiac Event Trial in Petah Tikva (Degarelix, GnRH agonist)
Unknown status
- Hormone Sensitive Prostate Cancer
- +2 more
- Degarelix
- GnRH agonist
-
Petah Tikva, IsraelRabin Medical Center - Beilinson Hospital
Nov 27, 2019